Neiry

About Neiry

Neiry operates as a neurotechnology developer, creating brain-computer interface (BCI) products for a wide array of sectors including education, entertainment, industry, and medicine. Founded in 2017 by Alexander Panov, the company is headquartered in Moscow, Russia. Panov, a serial entrepreneur, previously founded the successful marketing agency "KB-12" at age 19 before venturing into the deep-tech space with Neiry. His entrepreneurial journey reflects a persistent drive to tackle complex projects, including a side project that launched a satellite into orbit.

The firm's business model encompasses several revenue streams. Neiry develops and sells its own hardware, offers a full API for businesses to build their own neurotechnology-based products, and runs a partnership program for distributors. The company has secured significant funding, including a Series A round of 541 million rubles (approximately $7.4 million) in May 2021 from sources like the National Technology Initiative Support Fund and other investors, which valued the company at around 2.4 billion rubles ($32.6 million). Another funding round in June 2024 brought in 300 million rubles from the Voskhod venture capital fund and private investors to refine and commercialize products in new niches.

Neiry's product portfolio is diverse, featuring both non-invasive and invasive technologies. A core consumer product is the Mind Tracker, a portable EEG device available as headphones or a headband. This device tracks brain activity in real-time, translating EEG data into understandable metrics like fatigue, concentration, and stress levels via a companion app. The app provides exercises and courses designed to help users manage stress, improve focus, and enhance productivity. For developers and researchers, Neiry provides a Software Development Kit (SDK) to create custom software and experiments using their BCI hardware. The company is also developing Neiry Buds+, in-ear headphones with vagus nerve stimulation aimed at the medical market for treating conditions like depression and epilepsy.

In a more experimental and industrial direction, Neiry is developing invasive neurochips for what it terms "smart animals." This includes projects aimed at increasing milk yield in cows through neurostimulation and, more controversially, turning pigeons into remotely controllable "biodrones" for surveillance and monitoring by implanting chips in their brains. The company asserts that this technology allows an operator to upload flight tasks to the birds without behavioral training. Neiry's business strategy also includes acquisitions, such as its June 2025 purchase of Neurotrand, a company specializing in marketing research based on consumer emotional and behavioral responses.